Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1743studies shown
Showing 277-288 of 1,743
Drug study icon
CompletedEUCTR 2008-006738-85

A Single Dose, Open-Label, Randomized, Two-Way Crossover Food Effect Study Comparing 12.5 mg FazaClo™ (clozapine) ODT under Fasted and Fed Conditions in Healthy Male Volunteers.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
SchizophreniaDrugA study involving a medication or substance.
Countries
United Kingdom
Sponsor
Azur Pharma, Ltd.
Condition
Schizophrenia
Other study type icon
TerminatedNCT05109195

A Standard of Care Study of people with Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant

This study was terminated in the United States and in the United Kingdom. It focuses on depression.

In United Kingdom
DepressionObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 74 Years
Countries
United States, United Kingdom
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Other study type icon
CompletedNCT05841030

A Study in people with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

This study is completed in the United States, in France, in Canada, .... It focuses on depression.

In United Kingdom
DepressionObservationalFrom 18 Years to 74 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT00300846

Treatment of Aripiprazole for Schizophrenia

This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing treatment of Aripiprazole for Schizophrenia.

In United Kingdom
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
France, United Kingdom, Switzerland, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT05550532

Aticaprant 10 Milligrams (mg) for Depression

This study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.

In United Kingdom
DepressionDrugFrom 18 Years to 74 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT02006628

GWP42003 for schizophrenia

This study is completed in the United Kingdom, in Poland, and in Romania. It is testing GWP42003 for schizophrenia.

In United Kingdom
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United Kingdom, Poland, Romania
Sponsor
Jazz Pharmaceuticals
Condition
Schizophrenia
Drug study icon
CompletedNCT04080752

JNJ-61393215 for depression

This study is completed in the United States, in the United Kingdom, in Moldova, .... It is testing JNJ-61393215 for depression.

In United Kingdom
DepressionDrugFrom 18 Years to 64 Years
Countries
United States, United Kingdom, Moldova, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT05029401

Oral Ibogaine in Opioid Withdrawal

This study is completed in the United Kingdom. It is testing ibogaine for Addiction.

In United Kingdom
AddictionDrugFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
atai Therapeutics, Inc.
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.